Live Breaking News & Updates on Analyst Recommendations For Rocket Pharmaceuticals|Page 9

Stay updated with breaking news from Analyst recommendations for rocket pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $51.09 Average Price Target from Analysts

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) has received a consensus rating of “Moderate Buy” from the thirteen brokerages that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and eleven have given a buy rating to the company. The average 12 month price target among brokerages […] ....

John Militello , William Blair , Life Insurance Co , Rocket Pharmaceuticals Inc , Kokusai Asset Management Co , Mitsubishi Ufj , Insider Activity At Rocket Pharmaceuticals , Analyst Recommendations For Rocket Pharmaceuticals , Wells Fargo Company , Rocket Pharmaceuticals Price Performance , Rocket Pharmaceuticals , Needham Company , News Ratings For Rocket Pharmaceuticals Daily , Get Rating , Life Insurance , Asset Management , Wells Fargo , Rocket Pharmaceuticals Daily ,

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and eleven have assigned a buy rating to the company. The average 1-year […] ....

New Zealand General , New Zealand , John Militello , William Blair , Rocket Pharmaceuticals Inc , Analyst Recommendations For Rocket Pharmaceuticals , Institutional Investors Weigh In On Rocket Pharmaceuticals , Rocket Pharmaceuticals Stock Performance , Wellington Management Group , Maverick Capital Ltd , Securities Exchange Commission , Blackrock Inc , Rocket Pharmaceuticals , Insider Activity At Rocket Pharmaceuticals , Rocket Pharmaceuticals Company Profile , News Ratings For Rocket Pharmaceuticals Daily , Vanguard Group Inc , Needham Company , Get Rating , Marketbeat Ratings , Exchange Commission , Management Group , Street Corp , Vanguard Group , Rocket Pharmaceuticals Daily , Nasdaq Rckt ,

StockNews.com Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)

Research analysts at StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also recently issued reports on the company. William Blair reiterated an “outperform” […] ....

John Militello , William Blair , Institutional Trading Of Rocket Pharmaceuticals , Clearstead Advisors , Morgan Stanley , Rocket Pharmaceuticals Stock , Great West Life Assurance Co , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , Advisor Group Holdings Inc , Insider Transactions At Rocket Pharmaceuticals , Needham Company , Securities Exchange Commission , Analyst Recommendations For Rocket Pharmaceuticals , Allspring Global Investments Holdings , Steward Partners Investment Advisory , Get Rating , Exchange Commission , Global Investments Holdings , Group Holdings , Partners Investment Advisory , Great West Life Assurance , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Initiated Coverage ,

Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a report issued on Thursday. The firm issued a sell rating on the biotechnology company’s stock. RCKT has been the topic of several other research reports. Morgan Stanley initiated coverage on shares of Rocket Pharmaceuticals in a research report on Wednesday, February […] ....

New Zealand General , New Zealand , William Blair , John Militello , Wellington Management Group , Rocket Pharmaceuticals Inc , Vanguard Group Inc , Rocket Pharmaceuticals Stock Performance , Rocket Pharmaceuticals , Needham Company , Maverick Capital Ltd , Analyst Recommendations For Rocket Pharmaceuticals , Morgan Stanley , Blackrock Inc , Institutional Investors Weigh In On Rocket Pharmaceuticals , News Ratings For Rocket Pharmaceuticals Daily , Insider Transactions At Rocket Pharmaceuticals , Get Rating , Chardan Capital , Moderate Buy , Management Group , Street Corp , Vanguard Group , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Initiated Coverage ,

Rocket Pharmaceuticals (NASDAQ:RCKT) Receives New Coverage from Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research note issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. A number of other equities analysts have also recently issued reports on the company. Needham & Company LLC restated a “buy” rating […] ....

New Zealand General , New Zealand , Gaurav Shah , William Blair , John Militello , Needham Company , Rocket Pharmaceuticals Inc , Morgan Stanley , Hedge Funds Weigh In On Rocket Pharmaceuticals , Analyst Recommendations For Rocket Pharmaceuticals , Rocket Pharmaceuticals , Goldman Sachs Group Inc , Rocket Pharmaceuticals Company Profile , Rocket Pharmaceuticals Trading , News Ratings For Rocket Pharmaceuticals Daily , Maverick Capital Ltd , Insider Transactions At Rocket Pharmaceuticals , Wellington Management Group , Get Rating , Partners Management , Sachs Group , Street Corp , Management Group , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Initiated Coverage ,